Physician profile
Samyuktha Devabhaktuni
NPI 1407273865
$1,979.59
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $646 · 2020: $633 · 2021: $673 · 2022: $27.37.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $343.24 | 2019-2021 | |
| Novo Nordisk INC | $240.57 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $178.63 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $148.72 | 2019-2021 | |
| Amgen INC. | $147.27 | 2019-2021 | |
| Glaxosmithkline, LLC. | $145.39 | 2019-2021 | |
| Eisai INC. | $136.63 | 2020-2021 | |
| Abbott Laboratories | $88.99 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $67.79 | 2019-2021 | |
| Astellas Pharma US INC | $61.00 | 2021 | |
| Radius Health, INC. | $54.70 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $48.15 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $43.35 | 2019-2021 | |
| Lilly USA, LLC | $42.19 | 2019 | |
| Nestle Healthcare Nutrition INC. | $40.71 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $31.30 | 2019 | |
| Topcon Healthcare Solutions, INC. | $27.93 | 2019 | |
| Ge Healthcare | $21.96 | 2019 | |
| Arbor Pharmaceuticals, INC. | $19.71 | 2020 | |
| Dermira, INC. | $19.42 | 2020 | |
| Vanda Pharmaceuticals INC. | $18.39 | 2021 | |
| Almatica Pharma LLC | $14.74 | 2021 | |
| Medtronic Vascular, INC. | $13.95 | 2020 | |
| Pfizer INC. | $12.47 | 2019 | |
| Sanofi Pasteur INC. | $12.39 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samyuktha Devabhaktuni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.